It is well known that lymphangiogenesis in cancer is induced by tumor cells producing cytokines and growth factors like VEGF-A or C and angiopoietins, which bind to VEGF receptors-2 and -3 and Tie-2 at the surfaces of LECs located at quiescent lymphatic capillaries. The gene discussed is VEGFA; the disease is neoplasm.